Revi
Payments companies reported to CMS as associated with Revi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Revi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Revi
These are the largest totals companies reported as associated with Revi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Roger Dmochowski | Nashville, TN | Urology | $368,455.01 |
| Suzette Sutherland | Scottsdale, AZ | Urogynecology and Reconstructive Pelvic Surgery (Urology) | $226,001.87 |
| Stephanie Kielb | Ann Arbor, MI | Urology | $19,661.54 |
| Sandip Vasavada | Cleveland, OH | Urology | $16,178.30 |
| Eric Espinosa | Springfield, OH | Urology | $15,656.70 |
| Cindy Amundsen | Durham, NC | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $13,693.24 |
| Laura Giusto | Owings Mills, MD | Urology | $11,855.57 |
| Kimberly Ferrante | New York, NY | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $10,431.28 |
| Rebecca Mccrery | Omaha, NE | Urology | $6,274.03 |
| Gary Lemack | Dallas, TX | Urology | $2,833.34 |
Prescribed Revi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.